Log In
BCIQ
Print this Print this
 

BEMA Granisetron

  Manage Alerts
Collapse Summary General Information
Company BioDelivery Sciences International Inc.
DescriptionBioErodible MucoAdhesive (BEMA) formulation of granisetron, a serotonin (5-HT3) receptor antagonist
Molecular Target Serotonin (5-HT3) receptor
Mechanism of ActionSerotonin (5-HT3) receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationEmesis
Indication DetailsTreat nausea and vomiting associated with cancer therapy
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today